| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:730990 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EFNA1 mRNA | CTD | PMID:22079256 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:730991 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of EFNA1 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:730991 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EFNA1 mRNA; more ... | CTD | PMID:20230807 |
| 17beta-estradiol | decreases expression | ISO | RGD:730990 | 6480464 | Estradiol results in decreased expression of EFNA1 mRNA | CTD | PMID:15072547 PMID:15223131 |
| 17beta-estradiol | decreases expression | ISO | RGD:730990 | 6480464 | Estradiol results in decreased expression of EFNA1 mRNA | CTD | PMID:15072547 more ... |
| 17beta-estradiol | decreases expression | ISO | RGD:730990 | 6480464 | Estradiol results in decreased expression of EFNA1 mRNA | CTD | PMID:15223131 PMID:15072547 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:730990 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EFNA1 mRNA | CTD | PMID:12377990 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:730991 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EFNA1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:730991 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EFNA1 mRNA | CTD | PMID:18172886 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of EFNA1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of EFNA1 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:730990 | 6480464 | beta-methylcholine affects the expression of EFNA1 mRNA | CTD | PMID:21179406 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of EFNA1 mRNA | CTD | PMID:19162173 |
| acetaldehyde | affects expression | ISO | RGD:730991 | 6480464 | Acetaldehyde affects the expression of EFNA1 mRNA | CTD | PMID:22634333 |
| afimoxifene | multiple interactions | ISO | RGD:730990 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estrogens results in decreased expression of EFNA1 mRNA] | CTD | PMID:21233418 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of EFNA1 mRNA | CTD | PMID:20488242 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EFNA1 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | increases expression | ISO | RGD:730991 | 6480464 | arsenite results in increased expression of EFNA1 mRNA | CTD | PMID:18191166 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730990 | 6480464 | Benzo(a)pyrene results in decreased expression of EFNA1 mRNA | CTD | PMID:17879257 |
| benzo[a]pyrene | increases expression | ISO | RGD:730991 | 6480464 | Benzo(a)pyrene results in increased expression of EFNA1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730991 | 6480464 | Benzo(a)pyrene results in decreased expression of EFNA1 mRNA | CTD | PMID:19770486 PMID:21569818 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730991 | 6480464 | Benzo(a)pyrene results in decreased expression of EFNA1 mRNA | CTD | PMID:21569818 PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:730991 | 6480464 | Benzo(a)pyrene results in decreased expression of EFNA1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:730990 | 6480464 | Benzo(a)pyrene results in increased expression of EFNA1 mRNA | CTD | PMID:20064835 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:730991 | 6480464 | Diethylhexyl Phthalate results in increased expression of EFNA1 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:730991 | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of EFNA1 mRNA] | CTD | PMID:19850644 |
| caffeine | multiple interactions | ISO | RGD:730991 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EFNA1 mRNA; more ... | CTD | PMID:20230807 |
| choline | multiple interactions | ISO | RGD:730991 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EFNA1 gene | CTD | PMID:20938992 |
| ciglitazone | multiple interactions | ISO | RGD:730990 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of EFNA1 mRNA | CTD | PMID:16197558 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:730991 | 6480464 | Ciguatoxins affects the expression of EFNA1 mRNA | CTD | PMID:18353800 |
| clofibrate | multiple interactions | ISO | RGD:730991 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of EFNA1 mRNA; more ... | CTD | PMID:17585979 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of EFNA1 mRNA | CTD | PMID:15691709 |
| copper(2+) sulfate | decreases expression | ISO | RGD:730990 | 6480464 | Copper Sulfate results in decreased expression of EFNA1 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:730990 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | decreases expression | ISO | RGD:730990 | 6480464 | Coumestrol results in decreased expression of EFNA1 mRNA | CTD | PMID:19167446 |
| cytarabine | decreases expression | ISO | RGD:730990 | 6480464 | Cytarabine results in decreased expression of EFNA1 mRNA | CTD | PMID:21198554 |
| diarsenic trioxide | increases expression | ISO | RGD:730990 | 6480464 | arsenic trioxide results in increased expression of EFNA1 mRNA | CTD | PMID:20458559 |
| dioxygen | increases expression | ISO | RGD:730990 | 6480464 | Oxygen deficiency results in increased expression of EFNA1 mRNA | CTD | PMID:20042640 |
| folic acid | multiple interactions | ISO | RGD:730991 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EFNA1 gene | CTD | PMID:20938992 |
| fulvestrant | increases expression | ISO | RGD:730990 | 6480464 | fulvestrant results in increased expression of EFNA1 mRNA | CTD | PMID:15072547 |
| hydrogen peroxide | affects expression | ISO | RGD:730990 | 6480464 | Hydrogen Peroxide affects the expression of EFNA1 mRNA | CTD | PMID:20044591 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA | CTD | PMID:22129741 |
| L-methionine | multiple interactions | ISO | RGD:730991 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EFNA1 gene | CTD | PMID:20938992 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:730991 | 6480464 | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EFNA1 mRNA] | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:730991 | 6480464 | Diethylnitrosamine results in increased expression of EFNA1 mRNA | CTD | PMID:18691550 |
| nickel dichloride | increases expression | ISO | RGD:730990 | 6480464 | nickel chloride results in increased expression of EFNA1 mRNA | CTD | PMID:17312168 |
| nickel sulfate | multiple interactions | ISO | RGD:730990 | 6480464 | [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of EFNA1 mRNA | CTD | PMID:18832182 |
| nickel sulfate | increases expression | ISO | RGD:730990 | 6480464 | nickel sulfate results in increased expression of EFNA1 mRNA | CTD | PMID:18651567 |
| paclitaxel | decreases expression | ISO | RGD:730990 | 6480464 | Paclitaxel results in decreased expression of EFNA1 mRNA | CTD | PMID:19682730 |
| paracetamol | multiple interactions | ISO | RGD:730991 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of EFNA1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:730990 | 6480464 | Acetaminophen results in decreased expression of EFNA1 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:730991 | 6480464 | Acetaminophen affects the expression of EFNA1 mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:730991 | 6480464 | perfluorooctane sulfonic acid affects the expression of EFNA1 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | affects expression | ISO | RGD:730991 | 6480464 | perfluorooctanoic acid affects the expression of EFNA1 mRNA | CTD | PMID:19429403 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of EFNA1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:730990 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of EFNA1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of EFNA1 mRNA | CTD | PMID:19162173 |
| progesterone | increases expression | ISO | RGD:730990 | 6480464 | Progesterone results in increased expression of EFNA1 mRNA | CTD | PMID:18037150 |
| quercetin | decreases expression | ISO | RGD:730990 | 6480464 | Quercetin results in decreased expression of EFNA1 mRNA | CTD | PMID:21632981 |
| ranitidine | multiple interactions | EXP | | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of EFNA1 mRNA] | CTD | PMID:16415329 |
| resveratrol | multiple interactions | ISO | RGD:730990 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA | CTD | PMID:19167446 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of EFNA1 mRNA | CTD | PMID:15967596 |
| tamoxifen | affects expression | ISO | RGD:730991 | 6480464 | Tamoxifen affects the expression of EFNA1 mRNA | CTD | PMID:20937368 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of EFNA1 mRNA | CTD | PMID:16644059 |
| trans-resveratrol | multiple interactions | ISO | RGD:730990 | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of EFNA1 mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | decreases expression | ISO | RGD:730991 | 6480464 | trimellitic anhydride results in decreased expression of EFNA1 mRNA | CTD | PMID:19042947 |
| troglitazone | increases expression | ISO | RGD:730990 | 6480464 | troglitazone results in increased expression of EFNA1 mRNA | CTD | PMID:19140230 |
| zinc sulfate | increases expression | ISO | RGD:730990 | 6480464 | Zinc Sulfate results in increased expression of EFNA1 mRNA | CTD | PMID:16330358 |